Citation Impact
Citing Papers
Clodronate Reduces the Incidence of Fractures in Community-Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double-Blind, Placebo-Controlled Randomized Study
2006
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
2004
Gender variations in clinical pain experience
1996 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2008
The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly Women
1993
Postmenopausal osteoporosis: patient choices and outcomes
1995
Relative risk factors for osteoporotic fracture: A pilot study of the MEDOS questionnaire
1991
The Relationship of Oral Contraceptive Use to Rheumatoid Arthritis
1990
A New Approach to the Development of Assessment Guidelines for Osteoporosis
2002
Incidence and Direct Medical Costs of Hospitalizations due to Osteoporotic Fractures in Switzerland
1997
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Lyme Disease
1989 Standout
A reference standard for the description of osteoporosis
2007
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study
2004
Exogenous sex hormones and the risk of rheumatoid arthritis
1990
Rheumatoid arthritis
2016 Standout
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study
2014 Standout
Ovarian malignancy in patients with dermatomyositis and polymyositis: A retrospective analysis of fourteen cases
1997
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Body mass index as a predictor of fracture risk: A meta-analysis
2005
Serum Retinol Levels and the Risk of Fracture
2003
Prevalence of large-joint osteoarthritis in Asian and Caucasian skeletal populations
2001
Estrogens and Arthritis
2005
The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
1995 Standout
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis
1994
Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability
1996
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
2002
Comparison of the European and USA Practice Guidelines for Osteoporosis
2000
Intervention thresholds for osteoporosis in the UK
2004
Vitamin D Deficiency
2007 Standout
Prediction of fracture from low bone mineral density measurements overestimates risk
2000
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
1993 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Lymphoma subtypes in patients with rheumatoid arthritis: Increased proportion of diffuse large B cell lymphoma
2003
Selenium and human health
2012 Standout
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma
1998
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Scleroderma
2009 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Intervention thresholds for osteoporosis
2002
Osteoporosis: now and the future
2011 Standout
Different risk profiles for hip fractures and distal forearm fractures: A prospective study
1996
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
2000
Osteoarthritis
2015 Standout
Kashin–Beck Osteoarthropathy in Rural Tibet in Relation to Selenium and Iodine Status
1998 Standout
Cancer and interstitial lung disease
2004
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
Epidemiological features of chronic low-back pain
1999 Standout
Oral contraceptives and rheumatoid arthritis: Results from a primary care-based incident case-control study
1997
The experience of pain and emergent osteoarthritis of the knee
2001
Do Men and Women Fracture Bones at Similar Bone Densities?
2000
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
2010
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
The mortality of rheumatoid arthritis
1994
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Requirements for DXA for the management of osteoporosis in Europe
2004
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
Retinitis pigmentosa
2006 Standout
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Cost-Effectiveness of Preventing Hip Fracture in the General Female Population
2001
Descriptive Epidemiology and Public Health Aspects of Low Back Pain
1989
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
2001 Standout
Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use
1990
Geographic Variation in Rheumatoid Arthritis Incidence Among Women in the United States
2008
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Assessment of fracture risk
2004
The incidence and risk of hip fracture in Poland
2008
Effect and Offset of Effect of Treatments for Hip Fracture on Health Outcomes
1999
Interpretation and use of FRAX in clinical practice
2011
HORMONAL ALTERATIONS IN RHEUMATOID ARTHRITIS, INCLUDING THE EFFECTS OF PREGNANCY
2000
Rheumatoid arthritis
2010 Standout
Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women
1997
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The influence of alcohol consumption on the risk of vertebral deformity
1997
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
At what hip fracture risk is it cost-effective to treat?
2006
Actual Causes of Death in the United States, 2000
2004 Standout
Routine vs Extensive Malignancy Search for Adult Dermatomyositis and Polymyositis
2002
Epidemiology of hip fractures: Implications of the exponential increase with age
1996
Dermatomyositis
2000
A meta-analysis of milk intake and fracture risk: low utility for case finding
2004
Rheumatic disease in a Philippine village II: A WHO-ILAR-APLAR COPCORD study, phases II and III
1991
Prevalence of Vitamin D Insufficiency in an Adult Normal Population
1997 Standout
Evaluation of the risk of hip fracture
1996
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Risk of cancer in patients with dermatomyositis or polymyositis and follow-up implications: a Scottish population-based cohort study
2001
Pitfalls in the external validation of FRAX
2011
Osteoarthritis
2019 Standout
Polymyositis and dermatomyositis
2003 Standout
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
2007
Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria
2002
Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations
2013
Inflammatory muscle diseases
2001
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
The changing picture of hip fractures: dramatic change in age distribution and no change in age-adjusted incidence within 10 years in central Finland
1999
Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark
1995
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Bone loss in the elderly
1994
Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study
2003
Paraneoplastic syndromes of the spinal cord, nerve, and muscle
2000
Alcohol intake as a risk factor for fracture
2004
The course of established rheumatoid arthritis
2007
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
2004
Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations
2012
Reassessment of Twelve Traditional Paradigms Concerning the Diagnosis, Prevalence, Morbidity and Mortality of Rheumatoid Arthritis
1989
Secondary osteoporosis and the risk of distal forearm fractures in men and women
2002
Cancer of the Ovary
2004 Standout
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club
2005
Selenium in Human Health and Disease
2010
The Complex Role of Estrogens in Inflammation
2007 Standout
Do Oral Contraceptives Prevent Rheumatoid Arthritis?
1985
Spirochetes Isolated from the Blood of Two Patients with Lyme Disease
1983 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001
The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study
1996
Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study
2001
Polymyositis and Dermatomyositis
1975 Standout
Inflammatory Muscle Diseases
2015 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
International Variations in Hip Fracture Probabilities: Implications for Risk Assessment
2002
The quantification of drug-caused mortality and morbidity in Australia, 1998
2001
Lyme Disease—a Tick-Borne Spirochetosis?
1982 StandoutScience
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
2001
Oral contraceptives and rheumatoid arthritis: new data from the Royal College of General Practitioners' oral contraception study.
1990
Low back pain in eight areas of Britain.
1992
Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: consultations with a physician.
1993
Pain from the Neck-Shoulder Region and Sick Leave
1980
From Density to Structure: Growing Up and Growing Old on the Surfaces of Bone
1997
Bone Density Variation and Its Effects on Risk of Vertebral Deformity in Men and Women Studied in Thirteen European Centers: The EVOS Study
1997
Lyme Carditis: Cardiac Abnormalities of Lyme Disease
1980
Smoking and fracture risk: a meta-analysis
2004
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
THE SYNDROME OF MYASTHENIA AND POLYMYOSITIS WITH COMMENTS ON THERAPY*
1971
Timing and quantification of bone loss in cardiac transplant recipients
1995
Raloxifene preserves bone strength and bone mass in ovariectomized rats.
1994
Who Has Osteoporosis? A Conflict Between Clinical and Public Health Perspectives
2000
The Association of Nonsteroidal Anti-inflammatory Drugs With Upper Gastrointestinal Tract Bleeding
1987
The diagnosis of osteoporosis
1994 Standout
Mortality in rheumatoid arthritis: 2008 update.
2009
The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical Densitometry
2005
Biochemical and mechanical properties of subchondral bone in osteoarthritis.
2004
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Burden of major musculoskeletal conditions.
2003 Standout
The Spirochetal Etiology of Lyme Disease
1983 Standout
Diagnostic Dilemmas in Oncology
2001
Noncontraceptive Hormones and Rheumatoid Arthritis in Perimenopausal and Postmenopausal Women
1986
Oral contraceptives, cigarette smoking and other factors in relation to arthritis
1987
Works of Erik Allander being referenced
Osteoarthritis protects against femoral neck fracture: The MEDOS study experience
1993
Risk of Cancer in Patients with Dermatomyositis or Polymyositis
1992
The variable incidence of hip fracture in Southern Europe: The MEDOS study
1994
The epidemiology of osteoporosis. A selective overview
1989
Risk Factors for Hip Fracture in Men from Southern Europe: The MEDOS Study
1999
The Mediterranean osteoporosis (MEDOS) study questionnaire
1991
Circumstances around the fall in a multinational hip fracture risk study: a diverse pattern for prevention
1998
Kashin-Beck disease. An Analysis of research and public health activities based on a bibliography 1849-1992
1994
Epidemiology of the rheumatic diseases
1994
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
1992
Regional Distribution of Rheumatic Complaints in Sweden
1981
Suicide patterns among physicians related to other academics as well as to the general population
1987
Do You Die from Rheumatism?
1976
Do Oral Contraceptives Reduce the Incidence of Rheumatoid Arthritis?:A Pilot Study Using the Stockholm County Medical Information System
1984
Rheumatic pain in a Philippine village
1985
A Seventeen-year Follow-up of a Population Survey of Rheumatoid Arthritis
1987
Rheumatic Disorders in a Health Survey: How Valid and Reliable are the Reports?
1984
Medium-term Trends in the Occurrence of Rheumatic Diseases in European Countries: Results of an Inquiry on Statistical Data
1986
Side-effects of Indomethacin
1964
Observations on rheumatic disease in Polynesia and the Philippines.
1983
Acth or Corticosteroids?: A Critical Review of Results and Possibilities in the Treatment of Severe Chronic Disease
1969
Increased Mortality Among Persons with Rheumatoid Arthritis, But Where RA Does Not Appear on Death Certificate:Eleven-Year Follow-Up of an Epidemiological Study
1981
Is Nørgaard's Radiological Sign for Early Rheumatoid Arthritis Reliable?: An Epidemological Approach
1973
Risk factors for hip fracture in european women: The MEDOS study
1995
Mortality in Rheumatoid Arthritis, Particularly as Regards Drug Use
1985
Rheumatic disorders in the Swedish population and health care system.
1981
Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
1988
Problems in the classification of cause of death diagnoses affecting the reliability of mortality statistics for rheumatoid arthritis
1985
The apparent incidence of hip fracture in Europe: A study of national register sources
1992
Rheumatic Fever and Yersinia Arthritis1Criteria and Diagnostic Problems in a Changing Disease Pattern
1975
Prevalence, Incidence, And Remission Rates of Some Common Rheumatic Diseases Or Syndromes
1974